WHO ICTRP trial
Prospective Phase III Trial of Hypofractionated Postmastectomy Radiation Therapy
ChiCTR1800015067 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800015067 |
|---|---|
| Public title | Prospective Phase III Trial of Hypofractionated Postmastectomy Radiation Therapy |
| Scientific title | Prospective Phase III Trial of Hypofractionated Postmastectomy Radiation Therapy |
| Primary sponsor | Department of Radiation Oncology, Chinese PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | III (Phase III study) |
| Countries | China |
| Conditions | Breast cancer |
| Interventions | hypofractionated radiotherapy group:hypofractionated radiotherapy;conventional radiotherapy:onventional radiotherapy |
| Registration date | Mar 6, 2018 |
| Target size | hypofractionated radiotherapy group:264;conventional radiotherapy:264 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: